Replimune Group, Inc.
REPL
$9.50
-$0.005-0.05%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 40.42% | 16.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.01% | 12.19% | |||
| Operating Income | -20.01% | -12.19% | |||
| Income Before Tax | -12.88% | -23.96% | |||
| Income Tax Expenses | -118.61% | -- | |||
| Earnings from Continuing Operations | -11.74% | -25.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.74% | -25.04% | |||
| EBIT | -20.01% | -12.19% | |||
| EBITDA | -15.63% | -12.60% | |||
| EPS Basic | -2.63% | -2.42% | |||
| Normalized Basic EPS | -3.66% | -1.55% | |||
| EPS Diluted | -2.63% | -2.42% | |||
| Normalized Diluted EPS | -3.66% | -1.55% | |||
| Average Basic Shares Outstanding | 8.88% | 22.08% | |||
| Average Diluted Shares Outstanding | 8.88% | 22.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||